About Crystalmorphix Technologies
Crystalmorphix Technologies is a Healthcare company based in Hyderabad (India) founded in 2011. It operates as a solid-state chemistry services for drug developers are provided. Its Indian entity Crystalmorphix Technologies Private Limited reported revenue of ₹91.2 Lakh. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Crystalmorphix Technologies is a provider of solid-state chemistry services for drug developers. Their research service portfolio includes polymorph, salt, and co-crystal screening, physicochemical characterization, amorphous form generation, and stabilization, crystallization process development, preformulation studies, and IP support, while their analytical services include qualitative and quantitative XRD analysis. The companys CEO was formerly the lead of the solid-state team at Aptuit Laurus and also a group leader a group leader in the Center of Excellence in Polymorphism and Particle Engineering at Dr.Reddys.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website crystalmorphix.com
- Legal Name Crystalmorphix Technologies Private Limited
- Date of Incorporation 17 Sep, 2011
- Jurisdiction Sangareddy, Telangana, India
- Annual Revenue₹91.2 Lakh
FY 2024 · 0% YoY
- Net Loss-₹3.4 Lakh
FY 2024 · -4% margin
- EBITDA₹2.6 Lakh
FY 2024 · 3% margin
Associated legal entities of Crystalmorphix Technologies
Crystalmorphix Technologies operates through Crystalmorphix Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Crystalmorphix Technologies Private Limited CIN U24100TG2011PTC076586 | Active | 17 Sep 2011 | Sangareddy, Telangana | ₹0.9 Cr | – | 2 | View details |
Board of directors of Crystalmorphix Technologies Private Limited (Crystalmorphix Technologies)
Crystalmorphix Technologies Private Limited is the primary company behind Crystalmorphix Technologies. The board of Crystalmorphix Technologies Private Limited currently have 2 directors; the longest-serving is Tirupati Venkateswarudu Muppidi, appointed in 2011. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tirupati Venkateswarudu Muppidi DIN 03614220 | Director | 17 Sep 2011 | 15 yrs 1 mo | Crystalmorphix Technologies Private Limited |
| Vamsee Krishna Muppidi DIN 03615064 | Director | 17 Sep 2011 | 15 yrs 1 mo | Crystalmorphix Technologies Private Limited |
Financials of Crystalmorphix Technologies
Figures of Crystalmorphix Technologies Private Limited, the primary company behind Crystalmorphix Technologies, for FY 2024. Revenue was ₹91.2 Lakh (0% year on year). Net loss was -₹3.4 Lakh (-4% margin). EBITDA was ₹2.6 Lakh (3% margin). Revenue has grown at a compounded annual rate of -2% over three years and +5% over five years.
- ₹91.2 LakhRevenue · FY 2024 · 0% YoY
- -₹3.4 LakhNet loss · -4% margin
- ₹2.6 LakhEBITDA · 3% margin
- ₹10 LakhPaid-up capital
- -2%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Crystalmorphix Technologies Private Limited are on its company page.
Detailed financial statements for Crystalmorphix Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Crystalmorphix Technologies
Crystalmorphix Technologies has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Crystalmorphix Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Crystalmorphix Technologies (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Crystalmorphix Technologies
Crystalmorphix Technologies was founded in 2011.
Crystalmorphix Technologies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Crystalmorphix Technologies, Crystalmorphix Technologies Private Limited, reported revenue of ₹91.2 Lakh for FY 2024, down 0% year on year.
Crystalmorphix Technologies is a provider of solid-state chemistry services for drug developers. Their research service portfolio includes polymorph, salt, and co-crystal screening, physicochemical characterization, amorphous form generation, and stabilization, crystallization process development, preformulation studies, and IP support, while their analytical services include qualitative and quantitative XRD analysis. The companys CEO was formerly the lead of the solid-state team at Aptuit Laurus and also a group leader a group leader in the Center of Excellence in Polymorphism and Particle Engineering at Dr.Reddys.
Crystalmorphix Technologies's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Crystalmorphix Technologies operates through Crystalmorphix Technologies Private Limited.
The legal entities of Crystalmorphix Technologies currently have 2 directors, including Tirupati Venkateswarudu Muppidi, Vamsee Krishna Muppidi.